Steven Bellon
2023
In 2023, Steven Bellon earned a total compensation of $1.2M as Chief Scientific Officer at Foghorn Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,600 |
|---|---|
| Option Awards | $614,894 |
| Salary | $445,000 |
| Other | $3,000 |
| Total | $1,187,494 |
Bellon received $614.9K in option awards, accounting for 52% of the total pay in 2023.
Bellon also received $124.6K in non-equity incentive plan, $445K in salary and $3K in other compensation.
Rankings
In 2023, Steven Bellon's compensation ranked 1,013th out of 2,918 executives tracked by ExecPay. In other words, Bellon earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,013 out of 2,918 | 65th |
Division Manufacturing | 607 out of 1,608 | 62nd |
Major group Chemicals And Allied Products | 417 out of 901 | 54th |
Industry group Drugs | 406 out of 864 | 53rd |
Industry Pharmaceutical Preparations | 279 out of 622 | 55th |
Source: SEC filing on May 3, 2024.
Bellon's colleagues
We found two more compensation records of executives who worked with Steven Bellon at Foghorn Therapeutics in 2023.